Beam Therapeutics
BEAM
BEAM
240 hedge funds and large institutions have $2.82B invested in Beam Therapeutics in 2022 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 96 increasing their positions, 44 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $3.63B → $2.82B (-$806M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
50% less call options, than puts
Call options by funds: $21.5M | Put options by funds: $42.7M
Holders
240
Holding in Top 10
3
Calls
$21.5M
Puts
$42.7M
Top Buyers
| 1 | +$85.6M | |
| 2 | +$28.8M | |
| 3 | +$25.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$18.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.1M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$10.2M | |
| 3 | -$8.3M | |
| 4 |
E
Ergoteles
New York
|
-$3.55M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.22M |